| Application no. and date | 17732082.7 (espacenet) (Federated) (European Patent Register), 20170619 | | Patent/reg. no. and date | DK/EP 3472362, 20230906 | | Publication date | 20190424 | | Priority no. and date | EP 16175045, 20160617 | | EP pub. no. and date |
EP 3472362 20190424 | | Effective date | | | Applicant/owner | F. Hoffmann-La Roche AG, Grenzacherstrasse 124
4070 Basel, CH | | Applicant ref. no. | | | Inventor | JAVANBAKHT, Hassan, Aeschenvorstadt 50
4051 Basel, CH,
MUELLER, Henrik, c/o F. Hoffmann-La Roche AG
Grenzacherstrasse 124
4070 Basel, CH,
OTTOSEN, Søren, Gyngemose Parkvej 37
4.tv, 2860 Søborg, DK,
PEDERSEN, Lykke, Dalmosevej 20, 2400 København NV, DK | | Representative | | | Opponent | | | IPC Class | A61K 31/4745 (2006.01) , A61K 31/519 (2006.01) , A61K 31/7125 (2006.01) , A61P 31/14 (2006.01) , A61P 31/20 (2006.01) , C12N 15/113 (2010.01) , C12Q 1/6883 (2018.01) , C12Q 1/70 (2006.01) | | Title | NUCLEIC ACID MOLECULES FOR REDUCTION OF PAPD5 OR PAPD7 MRNA FOR TREATING HEPATITIS B INFECTION | | Int. application no. | EP2017064980 | | Int. publication no. | WO2017216390 | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
